Rx · PZN 16235679, 16235691
NEVIRAPIN Teva 400 mg prolonged-release tablets
German trade nameNEVIRAPIN Teva 400 mg Retardtabletten
According to the data available to us: no longer marketed
No observed availability
0.0out of 10
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for NEVIRAPIN Teva 400 mg prolonged-release tablets.
Review purchasing termsNEVIRAPIN Teva 400 mg prolonged-release tablets contains the active ingredient Nevirapine (German Nevirapin) and comes as Prolonged-release tablets. 2 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.
Pack sizes · 2 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 16235679 | 0.0 | 0.0 | ~ €161 |
| 16235691 | 0.0 | 0.0 | ~ €519 |
According to the data available to us, NEVIRAPIN Teva 400 mg prolonged-release tablets is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.
Request a source of supply